Topic: ADAMTS13 regulation of von Willebrand Factor in Cardiovascular Disease.
Recent publications
Huse C, Anstensrud AK, Michelsen AE, Ueland T, Broch K, Woxholt S, Yang K, Sharma K, Tøllefsen IM, Bendz B, Amundsen BH, Damås JK, Berg ES, Bjørkelund E, Quiles-Jiménez A, Bjerkeli V, Bendz C, Kleveland O, Stensaeth KH, Opdahl A, Kløw NE, Andersen GØ, Wiseth R, Halvorsen B, Gullestad Let al.(2022) Interleukin-6 inhibition in ST-elevation myocardial infarction: Immune cell profile in the randomised ASSAIL-MI trial EBioMedicine, 80, 104013(in press) DOI 10.1016/j.ebiom.2022.104013, PubMed 35504178
Kluge KE, Seljeflot I, Arnesen H, Jensen T, Halvorsen S, Helseth R(2022) Coagulation factors XI and XII as possible targets for anticoagulant therapy Thromb Res, 214, 53-62(in press) DOI 10.1016/j.thromres.2022.04.013, PubMed 35490644